News

AddToAny

Google+ Facebook Twitter Twitter

Obituary: Bev Groom

It is with deep sadness that we wish to inform you of the death of an IBMS member and colleague who passed away after losing her battle with cancer. Bev Groom passed away on 20 November 2020 at the age of 52.

Bev worked in pathology laboratories throughout her career. She started as a trainee biomedical scientist in September 1987, working in the pathology laboratory at North Tees and Hartlepool Hospital NHS Trust in Stockton on Tees.

Bev specialised in mycology, something that she went on to teach at both North Tees and South Tees.

Having taken some time away from the laboratory following the birth of Kirstie and James, she continued her passion of supporting patients.

In 2008, Bev joined pathology scientists at the James Cook University Hospital and deservedly gained promotion to a Senior Biomedical Scientist within the microbiology department at South Tees Hospitals.

Bev’s dedication to her role was demonstrated through her willingness to work despite her own poor health during the first wave of the pandemic, often staying late and supporting colleagues.  Unfortunately, her ill health took Bev away from the job and people she so loved.  

Bev formed many friendships over her years working at North and South Tees pathology laboratories and was considered a great teacher and a fantastic role model. She was an inspiration and will be greatly missed by all.

Related Articles

Medical Science Laboratory with Diverse Multi-Ethnic Team of Microbiology Scientists Have Meeting on Developing Drugs, Medicine, Doing Biotechnology Research-CREDIT_istock-1293772951

Equity, diversity and inclusion for all

Jemma Shead, a Senior Biomedical Scientist at Synnovis and IBMS EDI Working Group member, on how and why you should get involved with EDI.

adeno associated virus capsid-Image Credit | Science Photo Library - c0142837

Examining the medical mystery of child hepatitis outbreak

A study has shed light on an unexpected wave of severe acute hepatitis cases in 2022, amid the backdrop of the ongoing global COVID-19 pandemic.

clostridioides difficile bacteria-Image Credit | Science Photo Library - c0016337

Faecal microbiota transplant for C. diff

In the first comprehensive US evidence-based guideline on the use of faecal microbiota-based therapies for gastrointestinal disease, the American Gastroenterological Association recommends faecal microbiota transplant (FMT) for most patients with recurrent Clostridioides difficile (C. diff) infection.

pseudomonas aeruginosa bacteria Image-Credit | Science Photo Library - f0381226

Tackling priority pathogen with phages

A new study describes the use of phage therapy to eradicate multidrug-resistant Pseudomonas aeruginosa infections in vivo with important new implications for antibiotic resistance.

Top